CYRX
IndustrialsCryoport, Inc.
$9.83
+$0.27 (+2.82%)
Jan 5, 2026
Price History (1Y)
Analysis
Cryoport, Inc. is a publicly traded company operating in the Industrials sector within the Integrated Freight & Logistics industry. The company has a market capitalization of $492.18 million and annual revenues totaling $243.80 million, with approximately 1,090 employees. The financial health of Cryoport, Inc. is characterized by significant net losses, with a net income of -$60,669,000 over the trailing twelve months (TTM). The company also reports negative EBITDA and free cash flow, totaling -$19,846,000 and -$8,252,625, respectively. Notably, Cryoport's balance sheet indicates $421.31 million in cash reserves against $230.86 million in debt. Additionally, the company's gross margin stands at 45.5%, operating margin is -22.0%, and profit margin is 29.2%. Returns on equity and assets are also negative, at -11.3% and -4.4%, respectively. Cryoport's valuation context is marked by a forward P/E ratio of -16.84, indicating a significant discrepancy between the company's current stock price and its estimated future earnings growth. Revenue growth over the past year has been 15.4%. The dividend yield is not applicable, as the payout ratio is zero.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Cryoport, Inc.
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
Visit website →Key Statistics
- Market Cap
- $492.18M
- P/E Ratio
- N/A
- 52-Week High
- $11.44
- 52-Week Low
- $4.58
- Avg Volume
- 628.83K
- Beta
- 1.54
Company Info
- Industry
- Integrated Freight & Logistics
- Exchange
- NCM
- Country
- United States
- Employees
- 1,090